Difficulty: Medium
Average Score: 83%
Practice
Which of the following adverse effects of levodopa has a delayed onset and increases in severity with continued therapy?
Correct answer
D
Rationale
In this question, the correct answer is D) Abnormal movements. Levodopa is a precursor to dopamine used in the treatment of Parkinson's disease. One of the most common adverse effects of levodopa therapy is the development of abnormal involuntary movements known as dyskinesias. These abnormal movements typically have a delayed onset and tend to increase in severity with continued therapy, especially as the disease progresses.
Option A) Nausea and vomiting are common side effects of levodopa but usually occur early in treatment and can be managed with dose adjustments or concomitant medications.
Option B) Postural hypotension can occur with levodopa use but is more related to the dopaminergic effects on blood pressure regulation rather than delayed onset adverse effects.
Option C) Cardiac arrhythmias are not typically associated with levodopa therapy; they are more commonly seen with other medications or conditions.
Educationally, understanding the timing and progression of adverse effects of CNS stimulants like levodopa is crucial for healthcare professionals to effectively manage patients with Parkinson's disease. Recognizing the delayed onset and worsening of abnormal movements can guide treatment decisions and improve patient outcomes. It also underscores the importance of monitoring and adjusting therapy to balance the benefits of symptom control with the risks of adverse effects.
Option A) Nausea and vomiting are common side effects of levodopa but usually occur early in treatment and can be managed with dose adjustments or concomitant medications.
Option B) Postural hypotension can occur with levodopa use but is more related to the dopaminergic effects on blood pressure regulation rather than delayed onset adverse effects.
Option C) Cardiac arrhythmias are not typically associated with levodopa therapy; they are more commonly seen with other medications or conditions.
Educationally, understanding the timing and progression of adverse effects of CNS stimulants like levodopa is crucial for healthcare professionals to effectively manage patients with Parkinson's disease. Recognizing the delayed onset and worsening of abnormal movements can guide treatment decisions and improve patient outcomes. It also underscores the importance of monitoring and adjusting therapy to balance the benefits of symptom control with the risks of adverse effects.